NCT06082596 2023-10-13Study of BEBT-908 in Subjects With Advanced Hematological TumorsBeBetter Med IncPhase 1 Completed32 enrolled
NCT06074107 2023-10-11Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma SubjectsBeBetter Med IncPhase 2 Unknown128 enrolled